Translucent, a New York-based AI platform for healthcare finance, has raised $27 million in a Series A funding round.
Investors
The round was led by GV (Google Ventures), with continued participation from NEA, Virtue, and FPV Ventures.
Founded in 2009, GV is the corporate venture capital arm of Alphabet, based in San Francisco, California. It prefers to invest in the enterprise, life sciences, consumer, and frontier technology sectors. The firm has additional offices in Cambridge, London, and New York. GV has more than $10 billion in assets under management (AUM) and a portfolio of over 400 active companies.
Translucent Use of Funds
The company will use the funding to accelerate product development and expand its team as it brings real-time financial intelligence to more healthcare systems across the United States.
About Translucent
Led by CEO Jack O'Hara, Translucent is a company that provides an agentic AI platform designed specifically for healthcare organizations. Its platform consolidates operational, clinical, and financial data into a unified view, continuously monitoring signals across the organization to surface real-time financial insights and identify root causes the moment they emerge. Founded in 2024, Translucent is on a mission to modernize and simplify healthcare finance.
Funding Details
Company: Translucent AI, Inc.
Raised: $27.0M
Round: Series A
Funding Date: March 2026
Lead Investor: GV
Additional Investors: NEA, Virtue, FPV Ventures
Company Website: https://www.translucent.ai/
Software Category: AI Healthcare Finance
Source: https://www.businesswire.com/news/home/20260311059455/en/